Cancer Care’s "Shop-in-Shop" Moment: Oncare’s INR 27 Cr Series A Proves The Asset-Light Thesis Is Finally Hitting Oncology.
Gurugram-based Oncare has secured INR 27 crore...
Smart Capital Bets on "Centaurs," Not Just Code.
While the 2025 AI hype cycle promised fully autonomous enterprises, 2026 is delivering a harsh reality check:...
The definition of "Quick Commerce" is expanding beyond 10-minute grocery runs. HomeRun, a Bengaluru-based platform delivering construction and home-improvement materials, has secured $6.6 million...
The bottleneck in AI scaling is no longer just compute supply; it is power delivery. C2i Semiconductors, a Bangalore-based deep-tech player, has raised $15...
Headline: The $10 Million Mistake: Why Sam Altman Was Right About the Budget, But Wrong About the Battlefield
In June 2023, OpenAI’s Sam Altman famously...
HEADLINE: 70x Profit is the Hook. The 'AI-First' Hard Pivot is the Trap.
The Lede
Lenskart isn’t just selling spectacles anymore; it’s selling operating leverage....
The Clawdbot (technically now OpenClaw, following the January 2026 trademark collision with Anthropic) phenomenon is the single most polarizing development in the 2026 developer...
Ola Electric is no longer just a scooter company fighting for monthly dominance; it is a besieged ecosystem attempting a vertical leap into residential energy...
Executive Dispatch
The headline reads "grant funding for TB detection." The reality is a hostile takeover of the diagnostic value chain. The Bill & Melinda...